The Biosimilars market in Europe, as well as globally, will continue to grow significantly over the coming years. Tendering & Contracting is the main procurement mechanism for Biosimilars.
A solid understanding of the tender biosimilar market combined with the application of optimal tendering practices are critical for long-term success.
Nico Bacharidis, CCO of Cube RM, participated at the BioPharma Synergy Conference in Barcelona, an event that covers a diverse range of topics on Biosimilars, and presented an overview of the Biosimilars tendering market with a focus on Europe combined with strategies for a positive P&L impact and growth.
You can download the full deck by filling your details in the form below.